Complications of Blood Transfusions: Understanding the Risks

Blood transfusions are a common medical intervention used to treat a variety of conditions, from severe bleeding to anaemia. While they can be life-saving, they also carry certain risks and potential complications. Here are some of the most common complications associated with blood transfusions:

Transfusion haemosiderosis: Repeated blood transfusions can lead to the accumulation of iron in the body’s organs, particularly the heart and endocrine system. This can cause irreversible heart failure if left untreated.

High-output cardiac failure: While anaemia on its own may not be enough to cause heart failure, it can exacerbate the condition in those with reduced left ventricular systolic dysfunction.

Acute haemolytic transfusion reaction: This occurs when there is a mismatch between the major histocompatibility antigens on blood cells, such as the ABO system. It can cause severe intravascular haemolysis, disseminated intravascular coagulation, renal failure, and shock, and has a high mortality rate if not recognized and treated quickly.

Pulmonary oedema: While rare in patients with normal left ventricular systolic function, blood transfusions can cause fluid overload and pulmonary oedema, which can exacerbate chronic heart failure.

Transfusion-related bacterial endocarditis: While rare, bacterial infections can occur from blood transfusions. Platelet pools, which are stored at room temperature, have a slightly higher risk of bacterial contamination that can cause fulminant sepsis.

Understanding the potential complications of blood transfusions is important for both patients and healthcare providers. By recognizing and addressing these risks, we can ensure that blood transfusions remain a safe and effective treatment option for those who need them.

PrePex Device Offers Painless Male Circumcision for HIV Prevention

The PrePex device is a new method of male circumcision that is painless, sutureless, and does not require anaesthesia. It has been approved in countries such as Rwanda and is currently only available in sub-Saharan Africa. The World Health Organization (WHO) has found scientific evidence that male circumcision can significantly reduce the risk of HIV transmission. As a result, WHO is promoting this strategy in sub-Saharan Africa, where there has been a significant increase in the number of circumcision operations. However, it is important to note that circumcision should be used in conjunction with other measures, such as condom use, to reduce the incidence of HIV infection. The PrePex device is not designed for any other purposes.

Understanding Shaken Baby Syndrome

Shaken baby syndrome is a condition that involves a combination of retinal haemorrhages, subdural haematoma, and encephalopathy. It occurs when a child between the ages of 0-5 years old is intentionally shaken. However, there is controversy among physicians regarding the mechanism of injury, making it difficult for courts to convict suspects of causing shaken baby syndrome to a child. This condition has made headlines due to the ongoing debate among medical professionals.

Shaken baby syndrome is a serious condition that can cause long-term damage to a child’s health. It is important to understand the signs and symptoms of this condition to ensure that children are protected from harm. While the controversy surrounding the diagnosis of shaken baby syndrome continues, it is crucial to prioritize the safety and well-being of children. By raising awareness and educating the public about this condition, we can work towards preventing it from occurring in the future.

Sensitization occurs when fetal red blood cells, which are RhD-positive, enter the bloodstream of a mother who is RhD-negative. This can lead to the formation of antibodies in the mother’s circulation that can destroy fetal red blood cells, causing complications such as hemolytic disease of the fetus and newborn in subsequent pregnancies where the fetus is RhD-positive. To reduce the risk of sensitization, anti-D immunoglobulin is administered in situations where there is a likelihood of fetomaternal hemorrhage. Anti-D works by neutralizing RhD-antigens from fetal red cells, but it cannot reverse sensitization if the mother already has antibodies in her circulation. Prophylactic anti-D is given to non-sensitized RhD-negative women at 28 and 34 weeks to prevent small fetomaternal hemorrhages in the absence of a known sensitizing event. Various events during pregnancy, such as vaginal bleeding, chorionic villus sampling, and abdominal trauma, can potentially cause sensitization. Source: RCOG. Rhesus D prophylaxis, the use of anti-D immunoglobulin.

Rhesus negative pregnancies can lead to the formation of anti-D IgG antibodies in the mother if she delivers a Rh +ve child, which can cause haemolysis in future pregnancies. Prevention involves testing for D antibodies and giving anti-D prophylaxis to non-sensitised Rh -ve mothers at 28 and 34 weeks. Anti-D immunoglobulin should be given within 72 hours in various situations. Tests should be done on all babies born to Rh -ve mothers, and affected fetuses may experience various complications and require treatment such as transfusions and UV phototherapy.

Type 2 Diabetes and Drug Treatment Options

Type 2 diabetes is diagnosed when a person’s fasting plasma glucose level is consistently above 6.9 on two separate occasions. This condition is often associated with being overweight. To manage type 2 diabetes, drug treatment is necessary. The level of glycaemic lowering achieved through drug treatment is directly linked to a reduction in mortality.

Within 10 years of diagnosis, the rate of macrovascular complications is significantly higher than 20%. Therefore, it is crucial to choose the right drug therapy. The United Kingdom Prospective Diabetes Study (UKPDS) has shown that metformin is the preferred first-line drug therapy for type 2 diabetes.

Sulphonylureas are another drug therapy option, but they are associated with marginally higher cardiovascular mortality and weight gain. It is important to work with a healthcare professional to determine the best drug treatment plan for managing type 2 diabetes. By effectively managing blood glucose levels, individuals with type 2 diabetes can reduce their risk of complications and improve their overall health.

Understanding LSD Intoxication

LSD, also known as lysergic acid diethylamide, is a synthetic hallucinogen that gained popularity as a recreational drug in the 1960s to 1980s. While its usage has declined in recent years, it still persists, with adolescents and young adults being the most frequent users. LSD is one of the most potent psychoactive compounds known, and its psychedelic effects usually involve heightening or distortion of sensory stimuli and enhancement of feelings and introspection.

Patients with LSD toxicity typically present following acute panic reactions, massive ingestions, or unintentional ingestions. The symptoms of LSD intoxication are variable and can include impaired judgments, amplification of current mood, agitation, and drug-induced psychosis. Somatic symptoms such as nausea, headache, palpitations, dry mouth, drowsiness, and tremors may also occur. Signs of LSD intoxication can include tachycardia, hypertension, mydriasis, paresthesia, hyperreflexia, and pyrexia.

Massive overdoses of LSD can lead to complications such as respiratory arrest, coma, hyperthermia, autonomic dysfunction, and bleeding disorders. The diagnosis of LSD toxicity is mainly based on history and examination, as most urine drug screens do not pick up LSD.

Management of the intoxicated patient is dependent on the specific behavioral manifestation elicited by the drug. Agitation should be managed with supportive reassurance in a calm, stress-free environment, and benzodiazepines may be used if necessary. LSD-induced psychosis may require antipsychotics. Massive ingestions of LSD should be treated with supportive care, including respiratory support and endotracheal intubation if needed. Hypertension, tachycardia, and hyperthermia should be treated symptomatically, while hypotension should be treated initially with fluids and subsequently with vasopressors if required. Activated charcoal administration and gastric emptying are of little clinical value by the time a patient presents to the emergency department, as LSD is rapidly absorbed through the gastrointestinal tract.

In conclusion, understanding LSD intoxication is crucial for healthcare professionals to provide appropriate management and care for patients who present with symptoms of LSD toxicity.

Dry macular degeneration, also known as drusen, is a common cause of visual loss in individuals over the age of 50. The accumulation of lipid and protein debris around the macula is a strong indication of this condition. Wet macular degeneration, on the other hand, is characterized by choroidal neovascularization. Hypertensive retinopathy is typically associated with blot hemorrhages and cotton wool spots, while microaneurysms can indicate either hypertensive retinopathy or diabetic retinopathy. However, given the patient’s normal blood pressure and HbA1c levels, it is less likely that these findings are present.

Age-related macular degeneration (ARMD) is a common cause of blindness in the UK, characterized by the degeneration of the central retina (macula) and the formation of drusen. It is more prevalent in females and is strongly associated with advancing age, smoking, family history, and conditions that increase the risk of ischaemic cardiovascular disease. ARMD can be classified into two forms: dry and wet. Dry ARMD is more common and is characterized by drusen, while wet ARMD is characterized by choroidal neovascularisation and carries a worse prognosis. Clinical features of ARMD include subacute onset of visual loss, difficulties in dark adaptation, and visual disturbances such as photopsia and glare.

To diagnose ARMD, slit-lamp microscopy and color fundus photography are used to identify any pigmentary, exudative, or haemorrhagic changes affecting the retina. Fluorescein angiography and indocyanine green angiography may also be used to visualize changes in the choroidal circulation. Treatment for dry ARMD involves a combination of zinc with antioxidant vitamins A, C, and E, which has been shown to reduce disease progression by around one third. For wet ARMD, anti-VEGF agents such as ranibizumab, bevacizumab, and pegaptanib are used to limit disease progression and stabilize or reverse visual loss. Laser photocoagulation may also be used to slow progression, but anti-VEGF therapies are usually preferred due to the risk of acute visual loss after treatment.

In summary, ARMD is a common cause of blindness in the UK that is strongly associated with advancing age, smoking, and family history. It can be classified into dry and wet forms, with wet ARMD carrying a worse prognosis. Diagnosis involves the use of various imaging techniques, and treatment options include a combination of zinc and antioxidant vitamins for dry ARMD and anti-VEGF agents or laser photocoagulation for wet ARMD.

Limited cutaneous systemic sclerosis is a form of systemic sclerosis where the skin hardening is limited to the face and distal limbs, below the elbows. In contrast, diffuse cutaneous systemic sclerosis affects the trunk and proximal limbs. Sclerodactyly specifically refers to skin hardening of the fingers or toes. Dermatomyositis and systemic lupus erythematosus are inflammatory conditions that do not typically cause skin hardening. Psoriasis is a skin condition characterized by red, scaly patches of skin covered with silvery scales.

Understanding Systemic Sclerosis

Systemic sclerosis is a condition that affects the skin and other connective tissues, but its cause is unknown. It is more common in females, with three patterns of the disease. Limited cutaneous systemic sclerosis is characterised by Raynaud’s as the first sign, affecting the face and distal limbs, and associated with anti-centromere antibodies. CREST syndrome is a subtype of limited systemic sclerosis that includes Calcinosis, Raynaud’s phenomenon, oEsophageal dysmotility, Sclerodactyly, and Telangiectasia. Diffuse cutaneous systemic sclerosis affects the trunk and proximal limbs, associated with scl-70 antibodies, and has a poor prognosis. Respiratory involvement is the most common cause of death, with interstitial lung disease and pulmonary arterial hypertension being the primary complications. Renal disease and hypertension are also possible complications, and patients with renal disease should be started on an ACE inhibitor. Scleroderma without internal organ involvement is characterised by tightening and fibrosis of the skin, manifesting as plaques or linear. Antibodies such as ANA, RF, anti-scl-70, and anti-centromere are associated with different types of systemic sclerosis.

The recommended treatment for gestational diabetes is short-acting insulin, not longer-acting subcutaneous insulin. If lifestyle modifications and metformin do not improve the condition, the next step is to provide education on how to dose insulin in accordance with meals and offer short-acting insulin. Glibenclamide and gliclazide are not recommended for use in pregnancy due to the risk of adverse birth outcomes and neonatal hypoglycemia. Prescribing both drugs together or long-acting insulin is also not recommended. Short-acting insulin alone provides better postprandial glucose control and is more flexible in responding to the varying diets of pregnant women.

Gestational diabetes is a common medical disorder affecting around 4% of pregnancies. Risk factors include a high BMI, previous gestational diabetes, and family history of diabetes. Screening is done through an oral glucose tolerance test, and diagnostic thresholds have recently been updated. Management includes self-monitoring of blood glucose, diet and exercise advice, and medication if necessary. For pre-existing diabetes, weight loss and insulin are recommended, and tight glycemic control is important. Targets for self-monitoring include fasting glucose of 5.3 mmol/l and 1-2 hour post-meal glucose levels.

Biological Agents for the Treatment of Psoriasis

Psoriasis is a chronic autoimmune disease that affects the skin and joints. Biological agents have revolutionized the treatment of psoriasis by targeting specific molecules involved in the immune response. Here are some commonly used biological agents for the treatment of psoriasis:

Adalimumab: This agent targets tumor necrosis factor-alpha (TNF-alpha), a cytokine involved in systemic inflammation. Adalimumab is used when other systemic treatments have failed and the disease is severe.

Brodalumab: This agent targets the interleukin 17 receptor found on CD8+ cytotoxic T cells. It is used when methotrexate or ciclosporin have failed.

Infliximab: This agent is also a TNF-alpha inhibitor, but it has been shown to reactivate latent tuberculosis. Therefore, it should be used with caution in patients with a history of tuberculosis.

Guselkumab: This agent targets interleukin 23, which is involved in the activation of T17 lymphocytes. It is used in the treatment of moderate to severe psoriasis.

Secukinumab: This agent targets interleukin 17, which is found on CD8+ cytotoxic T cells. It is used in the treatment of moderate to severe psoriasis.

Before starting any of these agents, certain criteria must be met, such as failure of other treatments and severity of the disease. Additionally, some agents may be contraindicated in patients with certain medical histories, such as a history of tuberculosis.

Doxycycline, a type of antibiotic known as a tetracycline, is commonly used to prevent malaria, treat acne, and manage various sexually transmitted infections. However, it is important to note that taking doxycycline can make a person more sensitive to light. It is also contraindicated for pregnant women and children under 12 years old due to the risk of discoloration in developing bones and teeth, but this is not a concern for adult patients.

Drugs that can cause sensitivity to light

Photosensitivity is a condition where the skin becomes more sensitive to light, resulting in rashes, blisters, and other skin irritations. Certain drugs can cause photosensitivity, making it important to be aware of the medications that can cause this condition. Some of the drugs that can cause photosensitivity include thiazides, tetracyclines, sulphonamides, ciprofloxacin, amiodarone, NSAIDs like piroxicam, psoralens, and sulphonylureas.

Thiazides are a type of diuretic that can cause photosensitivity, while tetracyclines, sulphonamides, and ciprofloxacin are antibiotics that can also cause this condition. Amiodarone is a medication used to treat heart rhythm problems, but it can also cause photosensitivity. NSAIDs like piroxicam are pain relievers that can cause photosensitivity, while psoralens are used to treat skin conditions like psoriasis and can also cause photosensitivity. Sulphonylureas are medications used to treat diabetes that can cause photosensitivity as well.

It is important to note that not everyone who takes these medications will experience photosensitivity, but it is still important to be aware of the potential side effects.

Management of Intermittent Claudication in a Patient with Multiple Risk Factors

Intermittent claudication is a common symptom of arterial disease and can be caused by multiple risk factors, including smoking, diabetes, and hypercholesterolaemia. In managing a patient with intermittent claudication, it is important to first assess their ankle-brachial pressure index (ABPI) measurement to determine the severity of their arterial disease.

For patients with ABPI measurements between 0.6-0.9, first-line treatment involves managing risk factors and encouraging supervised exercise for three months. This patient should be optimally controlled for diabetes and compliant with their statin medication. Additionally, they should be prescribed 75 mg of clopidogrel daily to reduce the risk of blood clots.

A duplex USS arteriogram of both legs should be conducted to assess the extent of arterial disease. If necessary, a contrast-enhanced MRI may be used to plan revascularisation. However, surgery is typically only considered as a third-line treatment option.

It is important to note that analgesia is not the first-line treatment for intermittent claudication. Instead, addressing risk factors and enrolling in a supervised exercise programme for three months should be prioritised. Patients should be encouraged to exercise for two hours a week, to the maximum point of pain.

In summary, managing intermittent claudication in a patient with multiple risk factors involves a comprehensive approach that addresses risk factors, encourages exercise, and may involve further diagnostic testing and medication.

The primary concern in eclampsia is to manage seizures, which can be prevented and treated with magnesium sulphate as the first-line treatment. If magnesium sulphate is not available or ineffective, benzodiazepines like midazolam can be considered. Additionally, due to high blood pressure, antihypertensive drugs like Labetalol, Hydralazine, and Nifedipine are administered during pregnancy as they are effective and have low teratogenicity. Starting low dose aspirin before 16 weeks of gestation has been shown to significantly reduce the risk of pre-eclampsia.

Understanding Eclampsia and its Treatment

Eclampsia is a condition that occurs when seizures develop in association with pre-eclampsia, a pregnancy-induced hypertension that is characterized by proteinuria and occurs after 20 weeks of gestation. To prevent seizures in patients with severe pre-eclampsia and treat seizures once they develop, magnesium sulphate is commonly used. However, it is important to note that this medication should only be given once a decision to deliver has been made. In cases of eclampsia, an IV bolus of 4g over 5-10 minutes should be given, followed by an infusion of 1g/hour. During treatment, it is crucial to monitor urine output, reflexes, respiratory rate, and oxygen saturations. Respiratory depression can occur, and calcium gluconate is the first-line treatment for magnesium sulphate-induced respiratory depression. Treatment should continue for 24 hours after the last seizure or delivery, as around 40% of seizures occur post-partum. Additionally, fluid restriction is necessary to avoid the potentially serious consequences of fluid overload.

In summary, understanding the development of eclampsia and its treatment is crucial in managing this potentially life-threatening condition. Magnesium sulphate is the primary medication used to prevent and treat seizures, but it should only be given once a decision to deliver has been made. Monitoring vital signs and urine output is essential during treatment, and calcium gluconate should be readily available in case of respiratory depression. Finally, fluid restriction is necessary to avoid complications associated with fluid overload.

In cases of paracetamol overdose, liver transplantation may be considered if the arterial pH remains below 7.3 for more than 24 hours after ingestion. Other factors such as creatinine levels, encephalopathy grade, and INR must also be significantly abnormal to warrant transplantation.

Paracetamol overdose management guidelines were reviewed by the Commission on Human Medicines in 2012. The new guidelines removed the ‘high-risk’ treatment line on the normogram, meaning that all patients are treated the same regardless of their risk factors for hepatotoxicity. However, for situations outside of the normal parameters, it is recommended to consult the National Poisons Information Service/TOXBASE. Patients who present within an hour of overdose may benefit from activated charcoal to reduce drug absorption. Acetylcysteine should be given if the plasma paracetamol concentration is on or above a single treatment line joining points of 100 mg/L at 4 hours and 15 mg/L at 15 hours, regardless of risk factors of hepatotoxicity. Acetylcysteine is now infused over 1 hour to reduce adverse effects. Anaphylactoid reactions to IV acetylcysteine are generally treated by stopping the infusion, then restarting at a slower rate. The King’s College Hospital criteria for liver transplantation in paracetamol liver failure include arterial pH < 7.3, prothrombin time > 100 seconds, creatinine > 300 µmol/l, and grade III or IV encephalopathy.

Common Cranial Nerve Palsies and Horner Syndrome

Horner’s syndrome is a condition that affects the sympathetic trunk and causes ptosis, miosis, and anhidrosis. This syndrome is commonly associated with an apical lung lesion, especially in lifelong smokers. On the other hand, cranial nerve palsies affect the third, fifth, and seventh nerves, each with distinct symptoms.

Third nerve palsy causes ptosis and mydriasis, while trigeminal nerve palsy affects sensation and mastication but leaves the pupil unaffected. Facial nerve palsy, on the other hand, results in facial paralysis and the inability to close the affected eyelid, but it does not affect the pupil.

It is important to differentiate between these conditions as they have different underlying causes and treatments. A thorough neurological examination is necessary to determine the specific cranial nerve affected and the appropriate management plan.

In summary, understanding the differences between Horner’s syndrome and cranial nerve palsies is crucial in making an accurate diagnosis and providing optimal care for patients.

NICE updated guidelines on antenatal care in 2021, recommending the combined test for screening for Down’s syndrome between 11-13+6 weeks. The test includes nuchal translucency measurement, serum B-HCG, and pregnancy-associated plasma protein A (PAPP-A). The quadruple test is offered between 15-20 weeks for women who book later in pregnancy. Results are interpreted as either a ‘lower chance’ or ‘higher chance’ of chromosomal abnormalities. If a woman receives a ‘higher chance’ result, she may be offered a non-invasive prenatal screening test (NIPT) or a diagnostic test. NIPT analyzes cell-free fetal DNA in the mother’s blood and has high sensitivity and specificity for detecting chromosomal abnormalities. Private companies offer NIPT screening from 10 weeks gestation.

Boerhaave’s syndrome is a condition where the oesophagus ruptures spontaneously due to repeated episodes of vomiting. This man’s symptoms, including retrosternal chest pain and subcutaneous emphysema, are consistent with the classic triad of Boerhaave’s syndrome. Alcoholics and individuals with bulimia are at higher risk of developing this condition due to forceful vomiting against a closed glottis, which can cause a build-up of pressure in the oesophagus and lead to a transmural rupture. Urgent surgery is required for individuals with this condition, who tend to be systemically unwell.

Bleeding oesophageal varices, duodenal ulcer haemorrhage, and Mallory-Weiss syndrome are not the correct diagnoses for this man’s symptoms. Bleeding oesophageal varices typically present with life-threatening haematemesis, while duodenal ulcer haemorrhage causes hypotension, melena, and haematemesis. Mallory-Weiss syndrome is a small tear at the gastroesophageal junction that usually presents with haematemesis on a background of vomiting. None of these conditions would explain the subcutaneous emphysema or retrosternal chest pain seen in this case.

Boerhaave’s Syndrome: A Dangerous Rupture of the Oesophagus

Boerhaave’s syndrome is a serious condition that occurs when the oesophagus ruptures due to repeated episodes of vomiting. This rupture is typically located on the left side of the oesophagus and can cause sudden and severe chest pain. Patients may also experience subcutaneous emphysema, which is the presence of air under the skin of the chest wall.

To diagnose Boerhaave’s syndrome, a CT contrast swallow is typically performed. Treatment involves thoracotomy and lavage, with primary repair being feasible if surgery is performed within 12 hours of onset. If surgery is delayed beyond 12 hours, a T tube may be inserted to create a controlled fistula between the oesophagus and skin. However, delays beyond 24 hours are associated with a very high mortality rate.

Complications of Boerhaave’s syndrome can include severe sepsis, which occurs as a result of mediastinitis.

Although immediate CT is not necessary, patients should be admitted and closely monitored with a low threshold.

Criteria for Immediate CT Scan of Head in Paediatric Head Injury Cases

Head injuries in children can be serious and require immediate medical attention. In some cases, a CT scan of the head may be necessary to assess the extent of the injury. The following criteria are used to determine when an immediate CT scan is required:

– Loss of consciousness lasting more than 5 minutes (witnessed)
– Amnesia (antegrade or retrograde) lasting more than 5 minutes
– Abnormal drowsiness
– Three or more discrete episodes of vomiting
– Clinical suspicion of non-accidental injury
– Post-traumatic seizure but no history of epilepsy
– GCS less than 14, or for a baby under 1 year GCS (paediatric) less than 15, on assessment in the emergency department
– Suspicion of open or depressed skull injury or tense fontanelle
– Any sign of basal skull fracture (haemotympanum, panda’ eyes, cerebrospinal fluid leakage from the ear or nose, Battle’s sign)
– Focal neurological deficit
– If under 1 year, presence of bruise, swelling or laceration of more than 5 cm on the head
– Dangerous mechanism of injury (high-speed road traffic accident either as pedestrian, cyclist or vehicle occupant, fall from a height of greater than 3 m, high-speed injury from a projectile or an object)

It is important for healthcare professionals to be aware of these criteria and to promptly order a CT scan when necessary to ensure the best possible outcome for the child.

Diagnostic Imaging Techniques for Mesenteric Ischaemia

Mesenteric ischaemia is a condition that occurs when there is a lack of blood flow to the intestines, which can lead to serious complications. There are several diagnostic imaging techniques that can be used to identify mesenteric ischaemia, including abdominal computed tomography (CT), abdominal ultrasound, abdominal X-ray, colonoscopy, and magnetic resonance angiography (MRA).

Abdominal CT is often the first-line investigation used to rule out other causes and can identify signs of mesenteric ischaemia, such as gas in the intestinal wall and portal vein. Abdominal ultrasound is not useful in assessing bowel lesions but may indicate perforation and free fluid in the abdomen. Abdominal X-ray findings are non-specific and may not be helpful in narrowing down the differential. Colonoscopy can be helpful in looking at mucosal lesions of the bowel but carries a risk of perforation. MRA can be useful in assessing vascular pathology but is not recommended for patients with pacemakers.

In conclusion, a combination of diagnostic imaging techniques may be necessary to accurately diagnose mesenteric ischaemia and determine the appropriate treatment plan.

Diagnostic Tests for Benign Prostatic Hyperplasia

Benign prostatic hyperplasia is a common condition in older men that can cause urinary symptoms. To diagnose this condition, several diagnostic tests can be used. One of the most common tests is an ultrasound pelvis with post-void bladder volume, which can estimate the degree of bladder obstruction.

However, other tests such as CT abdomen and MRI abdomen are not useful for diagnosing benign prostatic hyperplasia. CT abdomen is more useful for diagnosing malignancies of the pelvic-ureteric system, while MRI abdomen is more sensitive for diagnosing lymph-node metastasis in prostate cancer.

Micturating cystourethrogram is also not useful for diagnosing prostatic hypertrophy, as it is used to diagnose fistula, vesicoureteric reflux, and urethral stricture. Similarly, serum alpha-fetoprotein has no role in cancer of the prostate, as it is a tumour marker in hepatocellular carcinoma, non-seminomatous germ-cell tumours, and yolk-sac tumours.

In conclusion, an ultrasound pelvis with post-void bladder volume is the most useful diagnostic test for benign prostatic hyperplasia.